PharmaShots | Incisive News in 3 Shots

Subscribe Now

Immune Thrombocytopenia

Hutchmed Initiates P-III ESLIM-01 Trial of HMPL-523 for the Treatment of Immune Thrombocytopenia in China

Hutchmed Initiates P-III ESLIM-01 Trial of HMPL-523 for the Treatment of Immune Thrombocytopenia in China

October 28, 2021

Sobi's Dova Pharmaceutical Reports Results of an Online Survey Highlighting Disease Burden and Impact for Patients with Immune Thrombocytopenia

Sobi's Dova Pharmaceutical Reports Results of an Online Survey Highlighting Disease Burden and Impact for Patients with Immune Thr...

December 9, 2019

Amgen's Nplate (Romiplostim) Receives FDA's Approval for Immune Thrombocytopenia Aged 1 year and Older

Amgen's Nplate (Romiplostim) Receives FDA's Approval for Immune Thrombocytopenia Aged 1 year and Older

December 17, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us